FDA approves generic Imitrex
(Forbes) UPDATED 2009-08-11
According to generic drugmaker Mylan, the U.S. Food and Drug Administration (FDA) has approved their generic version of the migraine med Imitrex. The FDA approval allows for the sale of sumitriptan in 25, 50, and 100 mg doses. Mylan says it has already begun shipping the medication.
Read full story >
See all Migraine News